Candel Therapeutics CADL
NASDAQ CADL
$10.69 -0.19 (-1.75%)
As of: Sep 30, 2026 · 12:55 PM EDT

Candel Therapeutics, Inc. (CADL) EBT Margin (2020 - 2022)

Updated

Candel Therapeutics (CADL) posted EBT Margin of -25403.23% for Q4 2022, down 400.00 percentage points from -25003.23% a year earlier but up 3812.90 percentage points from the prior quarter.

Analysis

Candel Therapeutics, Inc. (CADL) EBT Margin (2020 - 2022) Analysis & Trends

For FY2022, Candel Therapeutics' EBT Margin came in at -28169.60%, down 7546.40 percentage points from FY2021.

  • In prior years, Candel Therapeutics' EBT Margin was -20623.20% in FY2021 (-9664.00 pp) and -10959.20% in FY2020.
  • Quarterly EBT Margin has run from a low of -29551.61% in Q1 2022 to a high of -8145.16% in Q2 2020 over five years.
  • On a year-over-year basis, EBT Margin has declined in each of the last seven quarters, with an average year-over-year change of -8863.13 percentage points over the last seven quarters.
  • According to Business Quant data, EBT Margin for the three prior quarters was -29216.13% (Q3 2022), -29412.90% (Q2 2022) and -29551.61% (Q1 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -25,403.23%
Sep 30, 2022 -29,216.13%
Jun 30, 2022 -29,412.90%
Mar 31, 2022 -29,551.61%
Dec 31, 2021 -25,003.23%
Sep 30, 2021 -25,945.16%
Jun 30, 2021 -17,148.39%
Mar 31, 2021 -15,061.29%
Dec 31, 2020 -19,600.00%
Sep 30, 2020 -8,735.48%
Jun 30, 2020 -8,145.16%
API Access

Candel Therapeutics, Inc. EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=CADL&period=max&api_key=YOUR_API_KEY